Technical Analysis for DXCM - DexCom, Inc.

Grade Last Price % Change Price Change
grade A 260.75 -2.11% -5.63
DXCM closed down 2.11 percent on Friday, April 3, 2020, on 88 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical DXCM trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Stochastic Sell Signal Bearish -2.11%
50 DMA Support Bullish -2.11%
180 Bullish Setup Bullish Swing Setup -2.11%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.11%
Outside Day Range Expansion -2.11%
Wide Bands Range Expansion -2.11%
Overbought Stochastic Strength -2.11%
50 DMA Support Bullish 2.33%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments. The company's in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. It also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. The company markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Medicine Diabetes Healthcare Providers Endocrine System Diabetes Mellitus Endocrinology Medical Monitoring Software Platform Blood Glucose Monitoring Continuous Glucose Monitor Hyperglycemia Hypoglycemia

Is DXCM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 306.71
52 Week Low 107.44
Average Volume 1,222,169
200-Day Moving Average 196.69
50-Day Moving Average 254.74
20-Day Moving Average 241.28
10-Day Moving Average 252.82
Average True Range 21.62
ADX 21.8
+DI 22.42
-DI 17.04
Chandelier Exit (Long, 3 ATRs ) 226.98
Chandelier Exit (Short, 3 ATRs ) 246.94
Upper Bollinger Band 296.44
Lower Bollinger Band 186.11
Percent B (%b) 0.68
BandWidth 45.73
MACD Line 2.09
MACD Signal Line -2.57
MACD Histogram 4.6518
Fundamentals Value
Market Cap 22.59 Billion
Num Shares 86.6 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -343.09
Price-to-Sales 6.08
Price-to-Book 10.87
PEG Ratio -1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 283.87
Resistance 3 (R3) 285.21 278.84 280.01
Resistance 2 (R2) 278.84 272.96 278.17 278.73
Resistance 1 (R1) 269.80 269.32 266.62 268.46 277.44
Pivot Point 263.43 263.43 261.84 262.76 263.43
Support 1 (S1) 254.39 257.55 251.21 253.05 244.06
Support 2 (S2) 248.02 253.91 247.35 242.77
Support 3 (S3) 238.98 248.02 241.49
Support 4 (S4) 237.64